Proteomics

Dataset Information

0

Inhibition of Acyl-CoA Synthetase Long Chain (ACSL) Isozymes Decreases Multiple Myeloma Cell Proliferation, Mitochondrial Function and Affects Key Survival Pathways


ABSTRACT: Multiple myeloma (MM) is an incurable cancer of plasma cells that will cause ~12,590 deaths in the USA in 2023. Dysregulation of fatty acid (FA) metabolism is associated with MM development and progression but the underlying mechanisms remain unknown. The acyl-CoA synthetase long-chain family members (ACSLs) convert free long-chain fatty acids into fatty acyl-CoA esters, and play a key role in catabolic and anabolic fatty acid metabolism. Cancer Dependency Map data suggested that ACSL4 and ACSL3 are among the top 25% Hallmark Fatty Acid Metabolism genes that support MM fitness. Here, we show inhibition of the ACSLs in human myeloma cell lines using the pharmacological inhibitor Triascin C (TriC) caused apoptosis, and decreased proliferation in a dose- and time-dependent manner. As KRAS mutants are the most common mutation among MM patients, we used MM.1S cells to study the mechanisms of TriC toxicity. RNA-seq of MM.1S cells treated with TriC for 24 hours had transcriptomes significantly enriched in apoptosis, ferroptosis, and ER stress. Proteomics of MM.1S cells treated with TriC for 48 hours revealed that mitochondrial dysfunction and oxidative phosphorylation were significantly enriched pathways of interest. Indeed, metabolic flux analysis showed MM.1S cells treated with TriC after 24 hours had decreased mitochondrial ATP production rates. Flow cytometric analyses revealed decreases in mitochondrial number and membrane potential with increased mitochondrial superoxide levels. Implications: Overall, our data support the hypothesis that suppression of ACSL in human MM cells inhibited their growth and viability, potentially indicating that ACSL proteins may be promising therapeutic targets in treating myeloma progression.

INSTRUMENT(S): TripleTOF 5600

ORGANISM(S): Homo Sapiens (human)

TISSUE(S): B Cell, Cell Culture

DISEASE(S): Multiple Myeloma

SUBMITTER: Carlos Gartner  

LAB HEAD: Calvin Vary

PROVIDER: PXD049304 | Pride | 2025-06-16

REPOSITORIES: Pride

Dataset's files

Source:
Action DRS
gg_CMurph_111522_5600_IDA004.wiff Wiff
gg_CMurph_111522_5600_IDA004.wiff.scan Wiff
gg_CMurph_111522_5600_IDA005.wiff Wiff
gg_CMurph_111522_5600_IDA005.wiff.scan Wiff
gg_CMurph_111522_5600_IDA006.wiff Wiff
Items per page:
1 - 5 of 103
altmetric image

Publications

Inhibition of acyl-CoA synthetase long-chain isozymes decreases multiple myeloma cell proliferation and causes mitochondrial dysfunction.

Murphy Connor S CS   Fairfield Heather H   DeMambro Victoria E VE   Fadel Samaa S   Gartner Carlos A CA   Karam Michelle M   Potts Christian C   Rodriguez Princess P   Qiang Ya-Wei YW   Hamidi Habib H   Guan Xiangnan X   Vary Calvin P H CPH   Reagan Michaela R MR  

Molecular oncology 20250123 6


Multiple myeloma (MM) is an incurable cancer of plasma cells with a 5-year survival rate of 59%. Dysregulation of fatty acid (FA) metabolism is associated with MM development and progression; however, the underlying mechanisms remain unclear. Herein, we explore the roles of long-chain fatty acid coenzyme A ligase (ACSL) family members in MM. ACSLs convert free long-chain fatty acids into fatty acyl-CoA esters and play key roles in catabolic and anabolic fatty acid metabolism. Analysis of the Mul  ...[more]

Similar Datasets

2024-12-03 | GSE252929 | GEO
2022-11-21 | GSE193302 | GEO
2007-04-09 | GSE6980 | GEO
2023-01-12 | PXD032829 | Pride
2015-06-30 | E-GEOD-68259 | biostudies-arrayexpress
2015-06-30 | E-GEOD-68258 | biostudies-arrayexpress
2022-01-30 | GSE194381 | GEO
2020-11-01 | GSE143268 | GEO
2021-03-10 | GSE143267 | GEO
2022-11-21 | GSE193300 | GEO